Screener
Vor Biopharma VOR Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Vor Biopharma in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Vor Biopharma’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 8:31 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-220689
| (in thousands, except share and per share amounts) | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Property and equipment, net | 565 | 533 |
| Operating lease right-of-use assets | 2,827 | 2,936 |
| Other assets | 2,408 | 2,384 |
| Total assets | $506,746 | $464,126 |
| Liabilities and stockholders’ deficit | ||
| Current liabilities: | ||
| Accounts payable | $1,043 | $5,127 |
| Accrued liabilities | 14,727 | 19,764 |
Item 1. Financial Statements (Unaudited).
FAQ
- What is Vor Biopharma's total assets?
- Vor Biopharma (VOR) reported total assets of $506.75M in Q1 2026.
- How has Vor Biopharma's total assets changed year-over-year?
- Vor Biopharma's total assets increased by 363.6% year-over-year, from $109.31M to $506.75M.
- What is the long-term trend for Vor Biopharma's total assets?
- Over 5 years (2020 to 2025), Vor Biopharma's total assets has grown at a 43.6% compound annual growth rate (CAGR), from $75.91M to $464.13M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Vor Biopharma's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude